Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) EV/FCF
As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a EV/FCF of 16.3×. Over the past ten years it has ranged from −809× (June 2023) to 293× (November 2015); the current reading is higher than 56% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 52.2× | — |
| FY2024 | −23.5× | — |
| FY2023 | −140× | — |
| FY2022 | −656× | — |
| FY2021 | 10.2× | (18.29%) |
| FY2020 | 12.5× | (17.67%) |
| FY2019 | 15.2× | 21.89% |
| FY2018 | 12.5× | (45.79%) |
| FY2017 | 23.0× | 0.05% |
| FY2016 | 23.0× | (67.83%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 13.6× | (19.55%) |
| Jun 2026 | 16.9× | (4.17%) |
| Mar 2026 | 17.6× | (66.28%) |
| Dec 2025 | 52.2× | — |
| 37 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 8.3× |
| PHG Koninklijke Philips N.V. | 16.3× |
| BSX Boston Scientific Corporation compare | 22.7× |
| GEHC GE HealthCare Technologies Inc. compare | 24.6× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 24.6× |
| STE STERIS plc compare | 27.8× |
| DXCM DexCom, Inc. compare | 29.0× |
| EW Edwards Lifesciences Corporation compare | 39.3× |
| GKOS Glaukos Corporation compare | 360× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement